Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Rogers ( (ROG) ).
On July 30, 2025, Rogers Corporation announced cost-reduction initiatives for its curamik® reporting unit in response to market conditions, aiming to save over $13 million annually. These actions, expected to incur expenses between $12 million and $20 million, will involve employee severance and equipment relocation costs, with most cash outflows occurring in 2026. In its second-quarter 2025 financial results, Rogers reported a net sales increase of 6.5% to $202.8 million, despite a net loss of $73.6 million due to impairment charges. The company anticipates further improvements in the third quarter with higher sales and cost reduction measures.
The most recent analyst rating on (ROG) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on Rogers stock, see the ROG Stock Forecast page.
Spark’s Take on ROG Stock
According to Spark, TipRanks’ AI Analyst, ROG is a Neutral.
Rogers Corporation’s overall score is influenced by its stable financial base and low debt, but is weighed down by declining financial performance metrics and a high P/E ratio indicating overvaluation. Mixed technical signals and a cautious earnings call outlook further contribute to a moderate overall score.
To see Spark’s full report on ROG stock, click here.
More about Rogers
Rogers Corporation is a global leader in engineered materials, providing innovative solutions for applications in electric vehicles, automotive safety, radar systems, mobile devices, renewable energy, and more. Headquartered in Chandler, Arizona, the company operates manufacturing facilities in the U.S., Asia, and Europe, with sales offices worldwide.
Average Trading Volume: 199,491
Technical Sentiment Signal: Sell
Current Market Cap: $1.23B
Find detailed analytics on ROG stock on TipRanks’ Stock Analysis page.